Skip to main content

A multi-center, randomized, double-blind, parallel-group, multiple dose, adaptive study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of TTP399 in adult patients with type 1 diabetes mellitus.

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Endocrinology, Metabolism, and Nutrition

Awarded By

vTv Therapeutics LLC

Start Date

June 29, 2018

End Date

May 19, 2020
 

Administered By

Medicine, Endocrinology, Metabolism, and Nutrition

Awarded By

vTv Therapeutics LLC

Start Date

June 29, 2018

End Date

May 19, 2020